Genomma Lab Internacional, S.A.B. de C.V. Stock
Stocks
LAB B
MX01LA010006
Pharmaceuticals
OTC Markets Traded|
End-of-day quote
Mexican S.E.
2026-09-11
|
5-day change | 1st Jan Change | ||
| 12.64 MXN | -0.86% |
|
-2.84% | -29.35% |
| Market Cap | 12.32B 726M 626M 592M 537M 1.01B 69.37B 1.01B 7.04B 2.71B 35.29B 2.73B 2.67B 112B | P/E 2026 * |
6.68x | P/E 2027 * | 6.4x |
|---|---|---|---|---|---|
| Enterprise Value | 16.51B 973M 838M 794M 719M 1.35B 92.96B 1.36B 9.43B 3.63B 47.29B 3.65B 3.57B 149B | EV / Sales 2026 * |
0.92x | EV / Sales 2027 * | 0.85x |
| Free-Float |
68.95% | Yield 2026 * |
6.33% | Yield 2027 * | 8.48% |
| Markets | Quality | ||
|---|---|---|---|
Mexican S.E.
| LAB B | End-of-day quote | |
OTC Markets
| GNMLF | Delayed | |
|
Deutsche Boerse AG
| GEKA | Delayed |
Last Transcript : Genomma Lab Internacional, S.A.B. de C.V.
| 1 day | -0.86% | ||
| 1 week | -2.84% | ||
| Current month | -4.24% | ||
| 1 month | -10.04% | ||
| 3 months | -13.66% | ||
| 6 months | -29.11% | ||
| Current year | -29.35% |
| 1 week | 12.6 |  | 13.28 |
| 1 month | 12.6 | | 13.89 |
| Current year | 12.6 | | 19.48 |
| 1 year | 12.6 | | 20.9 |
| 3 years | 12.39 | | 29.18 |
| 5 years | 12.39 | | 29.18 |
| 10 years | 11.1 | | 29.18 |
| Manager | Title | Age | Since |
|---|---|---|---|
Marco Sparvieri
CEO | Chief Executive Officer | - | 2023-04-11 |
| Director of Finance/CFO | - | 2015-11-30 | |
| Investor Relations Contact | - | 2019-09-30 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | - | |
| Director/Board Member | - | 2016-12-31 | |
| Chairman | - | 1996-10-29 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.86% | -2.84% | -38.28% | -11.67% | 726M | |
| -0.65% | -2.93% | +47.70% | +86.17% | 994B | |
| -0.29% | -3.51% | +49.15% | +62.35% | 640B | |
| +0.83% | +0.26% | +17.76% | +72.25% | 454B | |
| -0.38% | -3.59% | +30.13% | +35.17% | 337B | |
| -0.09% | -13.54% | +13.34% | +24.95% | 261B | |
| -0.43% | -2.48% | -0.73% | +9.58% | 246B | |
| -1.34% | -13.70% | +36.53% | +44.96% | 204B | |
| -3.44% | -7.51% | -20.63% | -59.44% | 190B | |
| -0.75% | -4.82% | +25.46% | +87.14% | 178B | |
| Average | -0.74% | -5.62% | +16.04% | +35.15% | 350.55B | |
| Weighted average by Cap. | -0.51% | -4.42% | +30.94% | +54.93% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 17.99B 1.06B 913M 865M 784M 1.47B 101B 1.48B 10.27B 3.95B 51.52B 3.98B 3.89B 163B | 18.74B 1.1B 951M 901M 816M 1.53B 105B 1.54B 10.7B 4.11B 53.66B 4.15B 4.06B 170B |
| Net income | 1.91B 112M 96.75M 91.61M 83.04M 156M 10.73B 157M 1.09B 418M 5.46B 422M 412M 17.25B | 2.06B 121M 104M 98.92M 89.66M 168M 11.58B 169M 1.17B 452M 5.89B 455M 445M 18.62B |
| Net Debt | 4.19B 247M 213M 201M 183M 342M 23.59B 344M 2.39B 920M 12B 927M 907M 37.92B | 3.67B 216M 186M 176M 160M 300M 20.63B 301M 2.09B 805M 10.5B 811M 793M 33.17B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-11 | MX$12.64 | -0.86% | 2,230,183 |
| 26-09-10 | MX$12.75 | -1.47% | 3,890,174 |
| 26-09-09 | MX$12.94 | +1.33% | 3,434,600 |
| 26-09-08 | MX$12.77 | -3.40% | 3,611,340 |
| 26-09-07 | MX$13.22 | +1.61% | 872,571 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- LAB B Stock
Select your edition
All financial news and data tailored to specific country editions
